IP Library Assignment 037483/0049
Patent Assignment
Reel/Frame 037483/0049

Release of Security Interest

Recorded: 2016-01-13 Pages: 6
Assignor
Assignee
CREALTA PHARMACEUTICALS LLC
500 W. SILVER SPRING DRIVE, SUITE K-200, GLENDALE, WISCONSIN, 53217
Covered Properties (17)
Method for Ameliorating Muscle Weakness/Wasting in a Patient Infected with Human Immunodeficiency Virus-Type 1
Patent: 6,670,351 →
Application: 09/469,817 →
Specific Human Antibodies for Selective Cancer Therapy
Patent: 7,132,510 →
Application: 10/029,926 →
Publication: US 2004/0073011
Use of Oxandrolone in the Treatment of Burns and Other Wounds
Patent: 8,026,274 →
Application: 10/799,197 →
Publication: US 2004/0171673
Use of Oxandrolone in the Treatment of Burns and Other Wounds
Patent: 8,053,425 →
Application: 10/799,264 →
Publication: US 2004/0235940
Antibodies and uses thereof
Application: 11/166,740 →
Publication: US 2005/0266009
Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of Peg-Uricase
Patent: 8,148,123 →
Application: 11/539,475 →
Publication: US 2007/0274977
Purification of Proteins With Cationic Surfactant
Patent: 9,534,013 →
Application: 11/918,292 →
Publication: US 2009/0317889
Variant Form of Urate Oxidase and Use Thereof
Patent: 7,811,800 →
Application: 11/918,296 →
Publication: US 2009/0209021
Variant Forms of Urate Oxidase and Use Thereof
Patent: 8,188,224 →
Application: 11/918,297 →
Publication: US 2009/0169534
Variant Form of Urate Oxidase and Use Thereof
Patent: 7,964,381 →
Application: 12/879,084 →
Publication: US 2011/0104751
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,034,594 →
Application: 13/107,498 →
Publication: US 2011/0217755
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,178,334 →
Application: 13/226,891 →
Publication: US 2012/0070876
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Patent: 9,377,454 →
Application: 13/379,704 →
Publication: US 2012/0301454
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,293,228 →
Application: 13/452,151 →
Publication: US 2012/0225046
Variant Forms of Urate Oxidase and Use Thereof
Patent: 8,541,205 →
Application: 13/461,170 →
Publication: US 2012/0309085
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,465,735 →
Application: 13/623,512 →
Publication: US 2013/0084273
Variant Forms of Urate Oxidase and Use Thereof
Patent: 9,017,980 →
Application: 13/972,167 →
Publication: US 2013/0330803
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 20, 2002
From: HAGAY, YOCHEVED; LAZAROVITS, JANETTE; LIFSHITZ, ORLY; GUY, RACHEL
To: BIO-TECHNOLOGY GENERAL, INC.
Reel/Frame 013209/0794 →
Change of Name Oct 20, 2003
From: BIO-TECHNOLOGY GENERAL, INC.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014611/0880 →
Change of Name Jan 16, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014871/0808 →
Change of Name Jun 21, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014754/0469 →
Change of Name Dec 7, 2005
From: SAVIENT PHARMACEUTICALS, INC.
To: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
Reel/Frame 017100/0091 →
Assignment of Assignor's Interest Aug 28, 2007
From: REHRIG, CLAUDIA D.; HUANG, WILLIAM; HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 019756/0045 →
Assignment of Assignor's Interest Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020386/0145 →
Assignment of Assignor's Interest Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020384/0974 →
Assignment of Assignor's Interest Jan 18, 2008
From: FISCHER, MEIR; HAROSH, ELIYAHU
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020383/0946 →
Assignment of Assignor's Interest Jul 23, 2008
From: HERSHFIELD, MICHAEL S.
To: DUKE UNIVERSITY
Reel/Frame 021278/0683 →
Security Agreement Jun 12, 2012
From: SAVIENT PHARMACEUTICALS, INC.
To: MORGAN STANLEY SENIOR FUNDING INC.
Reel/Frame 028363/0040 →
Assignment of Assignor's Interest Aug 3, 2012
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 028715/0585 →
Corrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement. Jul 23, 2013
From: SAVIENT PHARMACEUTICALS, INC.
To: U.S. NATIONAL BANK ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030936/0072 →
Security Agreement Feb 21, 2014
From: CREALTA PHARMACEUTICALS LLC
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 032319/0077 →
Security Agreement Mar 4, 2014
From: CREALTA PHARMACEUTICALS LLC
To: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
Reel/Frame 032384/0285 →
Assignment of Assignor's Interest Apr 15, 2014
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, LLC
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 032675/0936 →
Assignment of Assignor's Interest Aug 18, 2015
From: SAVIENT PHARMACEUTICALS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 036388/0167 →
Release of Security Interest Jan 13, 2016
From: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 037483/0148 →
Change of Name Jul 5, 2016
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 039258/0154 →
Change of Name Jul 5, 2016
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 039258/0152 →
Patent Security Agreement Sep 16, 2016
From: HORIZON PHARMA RHEUMATOLOGY LLC (FORMERLY KNOWN AS CREALTA PHARMACEUTICALS LLC)
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040059/0007 →
Change of Name Nov 18, 2016
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 040648/0361 →
Change of Name Nov 18, 2016
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 040648/0367 →
Assignment of Assignor's Interest Sep 7, 2022
From: HORIZON THERAPEUTICS USA, INC.
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 061389/0471 →
Assignment of Assignor's Interest Oct 31, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC
Reel/Frame 061805/0076 →